EICHORCondition: Non-small Cell Lung Cancer · NSCLC · Sponsor: Merck Sharp & Dohme LLC
This is a phase 3 study of pembrolizumab in combination with carboplatin/taxane (paclitaxel or nab-paclitaxel) followed by pembrolizumab with or without maintenance sacituzumab tirumotecan (sac-TMT; MK-2870) in first-line treatment of metastatic squamous non-small cell lung cancer. It is hypothesized that pembrolizumab with maintenance sacituzumab tirumotecan is superior to pembrolizumab without sacituzumab tirumotecan maintenance with respect to overall survival (OS).
This description comes directly from the study's public registry record.
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
| CARTI Cancer Center ( Site 0006) | Little Rock, Arkansas, United States | Recruiting |
| Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0122) | Burbank, California, United States | Recruiting |
| Sharp Memorial Hospital ( Site 9544) | San Diego, California, United States | Recruiting |
| Intermountain Health Cancer Center Lutheran Hospital ( Site 0119) | Golden, Colorado, United States | Recruiting |
| Intermountain Health St. Mary's Regional Hospital ( Site 0116) | Grand Junction, Colorado, United States | Recruiting |
| Washington Hospital Center ( Site 0037) | Washington D.C., District of Columbia, United States | Recruiting |
| Mid Florida Hematology and Oncology Center ( Site 0109) | Orange City, Florida, United States | Completed |
| Centricity Research Columbus Cancer Center ( Site 0111) | Columbus, Georgia, United States | Completed |
| Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 0001) | Marietta, Georgia, United States | Completed |
| Southeastern Regional Medical Center ( Site 0004) | Newnan, Georgia, United States | Completed |
| University of Chicago Medical Center ( Site 0145) | Chicago, Illinois, United States | Recruiting |
| Trinity Health Saint Joseph Mercy Hospital Ann Arbor ( Site 9552) | Ypsilanti, Michigan, United States | Recruiting |
+ 203 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06422143